AMAG PHARMACEUTICALS, INC. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Option Exercise | A | 15.51 | 20,000 | 310,200 | 20,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Grant | A | 0.00 | 7,500 | 0 | 71,474 | 64 K to 71.5 K (+11.72 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Grant | A | 0.00 | 7,500 | 0 | 63,974 | 56.5 K to 64 K (+13.28 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Butcher James Alan | EVP, Chief Business ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Butcher James Alan | EVP, Chief Business ... | Grant | A | 0.00 | 15,000 | 0 | 53,418 | 38.4 K to 53.4 K (+39.04 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Butcher James Alan | EVP, Chief Business ... | Grant | A | 0.00 | 10,000 | 0 | 38,418 | 28.4 K to 38.4 K (+35.19 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Grant | A | 0.00 | 15,000 | 0 | 73,606 | 58.6 K to 73.6 K (+25.59 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Grant | A | 0.00 | 10,000 | 0 | 58,606 | 48.6 K to 58.6 K (+20.57 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 15.51 | 70,000 | 1,085,700 | 70,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 132,000 | 0 | 488,058 | 356.1 K to 488.1 K (+37.07 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Grant | A | 0.00 | 31,000 | 0 | 356,058 | 325.1 K to 356.1 K (+9.54 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 82,461 | 62.5 K to 82.5 K (+32.02 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Grant | A | 0.00 | 12,000 | 0 | 62,461 | 50.5 K to 62.5 K (+23.78 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 12,000 | 0 | 82,512 | 70.5 K to 82.5 K (+17.02 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Grant | A | 0.00 | 20,000 | 0 | 70,512 | 50.5 K to 70.5 K (+39.59 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 85,787 | 73.8 K to 85.8 K (+16.26 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 73,787 | 61.8 K to 73.8 K (+19.42 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 15.51 | 2,957 | 45,863 | 325,058 | 328 K to 325.1 K (-0.90 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 15.51 | 869 | 13,478 | 48,606 | 49.5 K to 48.6 K (-1.76 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 15.51 | 982 | 15,231 | 61,787 | 62.8 K to 61.8 K (-1.56 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | Chief Financial Off ... | Payment of Exercise | F | 15.51 | 869 | 13,478 | 50,461 | 51.3 K to 50.5 K (-1.69 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | EVP, General Counse ... | Payment of Exercise | F | 15.51 | 869 | 13,478 | 50,512 | 51.4 K to 50.5 K (-1.69 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Bolgiano Elizabeth Scott | Chief Human Resourc ... | Payment of Exercise | F | 15.51 | 695 | 10,779 | 56,474 | 57.2 K to 56.5 K (-1.22 %) |